A baby diagnosed with spinal muscular atrophy (SMA) was successfully treated in the womb for the first time. Now over two ...

An infant with a fatal genetic disease has survived past the age of 2 with no signs of the condition, thanks to treatment ...

Neurofilament light (NFL) is a powerful and sensitive biomarker for tracking neuronal health and disease progression.

Heart disease may run in your family but genes account for only 20-30 per cent of your risk of heart problems. The rest is ...

Doctors diagnosed Carmen Lopez with spinal muscle atrophy (SMA) at birth, a rare genetic disorder that affects motor neurons ...

May 23, 2024 — Treatment of autoimmune diseases like lupus has long relied on steroids to knock down the immune system, but more targeted therapies are currently undergoing clinical trials.

Researchers from Tokyo Metropolitan University have developed a way to treat ageing-related muscular atrophy using regenerative medicine.

Dyne is developing targeted therapeutics that deliver to muscle and the central nervous system (CNS). Dyne has a broad pipeline for neuromuscular diseases, including clinical programs for myotonic ...

Early onset Alzheimer’s disease is Alzheimer’s disease that starts before age 65. It’s rare under age 30 and more commonly affects people ages 50 and over. Early detection and treatment can ...

WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- A new spinal cord implant may help people with spinal muscular atrophy (SMA ... three adults with SMA -- a genetic disease that weakens muscles over time -- ...

“For 75 years, the Muscular Dystrophy Association has driven breakthroughs that once seemed out of reach, delivering hope and progress to families affected by neuromuscular diseases. This ...